BRWM
TXMD icon

B. Riley Wealth Management’s TherapeuticsMD TXMD Stock Holding History

B. Riley Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,700
Closed -$48K – 704
2021
Q4 		$48K Buy
2,700
+2,404
+812% +$72K ﹤0.01% 645
2021
Q3 		$11K Buy
+296
New +$13.1K ﹤0.01% 634
2021
Q1 		– Sell
-355
Closed -$21K – 483
2020
Q4 		$21K Sell
355
-640
-64% -$43.7K ﹤0.01% 383
2020
Q3 		$79K Buy
995
+200
+25% +$15.9K 0.01% 399
2020
Q2 		$50K Buy
+795
New +$46.3K 0.01% 411
2018
Q4 		– Sell
-312
Closed -$102K – 403
2018
Q3 		$102K Buy
+312
New +$95.6K 0.03% 305

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

B. Riley Wealth Management's TXMD Position: Q1 2022 in Review

B. Riley Wealth Management sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 2,700 shares — an estimated $48K sold.

B. Riley Wealth Management first reported a position in TXMD in Q3 2018 and held it in 6 quarters. The position peaked at $102K in Q3 2018. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

  • B. Riley Wealth Management reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
  • B. Riley Wealth Management sold 2,700 TherapeuticsMD shares in Q1 2022, an estimated $48K.
  • B. Riley Wealth Management first reported a position in TherapeuticsMD in Q3 2018 and held it in 6 quarters.
  • B. Riley Wealth Management's TherapeuticsMD position peaked at $102K in Q3 2018.
  • 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on B. Riley Wealth Management's 13F filing for Q1 2022, filed 10 May 2022.